Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$3.92B |
| 2 |
Visa
V
|
+$551M |
| 3 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$406M |
| 4 |
UnitedHealth
UNH
|
+$395M |
| 5 |
Advanced Micro Devices
AMD
|
+$363M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.41B |
| 2 |
NVIDIA
NVDA
|
+$2.28B |
| 3 |
Microsoft
MSFT
|
+$2.02B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.83B |
| 5 |
Flutter Entertainment
FLUT
|
+$962M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Consumer Discretionary | 7.14% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 4.81% |
| 5 | Communication Services | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
PUT
Western Digital
WDC
$187B
| $894K | ﹤0.01% |
19,845
-1,058
| -5% | -$53.2K |
|
3377
CALL
NovoCure
NVCR
$1.82B
| $894K | ﹤0.01% |
+30,000
| New | +$635K |
|
|
3378
PUT
NovoCure
NVCR
$1.82B
| $894K | ﹤0.01% |
+30,000
| New | +$635K |
|
3379
Farmers National Banc Corp
FMNB
$954M
| $891K | ﹤0.01% |
62,692
+6,762
| +12% | +$101K |
|
3380
iShares ESG Aware MSCI USA ETF
ESGU
$18.2B
| $889K | ﹤0.01% |
6,899
-5,000
| -42% | -$648K |
|
3381
Esquire Financial Holdings
ESQ
$1.11B
| $888K | ﹤0.01% |
11,173
+865
| +8% | +$62.1K |
|
3382
Entrada Therapeutics
TRDA
$287M
| $888K | ﹤0.01% |
51,365
+6,255
| +14% | +$113K |
|
3383
Global Industrial
GIC
$1.41B
| $885K | ﹤0.01% |
35,710
+5,088
| +17% | +$148K |
|
3384
The Honest Company
HNST
$415M
| $885K | ﹤0.01% |
127,726
+17,340
| +16% | +$98.2K |
|
3385
Stoke Therapeutics
STOK
$1.85B
| $884K | ﹤0.01% |
80,112
+372
| +0.5% | +$4.57K |
|
3386
Compass Minerals
CMP
$1.23B
| $883K | ﹤0.01% |
78,465
-14,338
| -15% | -$187K |
|
|
UHT
3387
Universal Health Realty Income Trust
UHT
$587M
| $882K | ﹤0.01% |
23,713
+861
| +4% | +$35.1K |
|
|
MTAL
3388
DELISTED
Metals Acquisition
MTAL
| $879K | ﹤0.01% |
82,780
+10,520
| +15% | +$130K |
|
3389
Scholastic
SCHL
$799M
| $878K | ﹤0.01% |
41,180
-48
| -0.1% | -$1.22K |
|
3390
Petco
WOOF
$825M
| $875K | ﹤0.01% |
229,599
+13,035
| +6% | +$58.9K |
|
|
ATXS
3391
DELISTED
Astria Therapeutics
ATXS
| $875K | ﹤0.01% |
97,820
+5,169
| +6% | +$54.9K |
|
3392
Willdan Group
WLDN
$1.15B
| $873K | ﹤0.01% |
22,924
+5,623
| +33% | +$241K |
|
3393
Zillow
ZG
$8.29B
| $872K | ﹤0.01% |
12,311
+1,790
| +17% | +$123K |
|
3394
Hingham Institution for Saving
HIFS
$654M
| $869K | ﹤0.01% |
3,418
+355
| +12% | +$94.1K |
|
|
LENZ
3395
LENZ Therapeutics
LENZ
$159M
| $868K | ﹤0.01% |
30,057
+13,594
| +83% | +$414K |
|
|
SVC
3396
Service Properties Trust
SVC
$1.01B
| $867K | ﹤0.01% |
68,262
+12,178
| +22% | +$197K |
|
3397
Acco Brands
ACCO
$409M
| $865K | ﹤0.01% |
164,727
+16,425
| +11% | +$91.2K |
|
3398
Ouster
OUST
$3.1B
| $861K | ﹤0.01% |
70,447
+13,117
| +23% | +$115K |
|
3399
Smith & Wesson
SWBI
$666M
| $861K | ﹤0.01% |
85,160
+4,711
| +6% | +$59K |
|
|
USAP
3400
DELISTED
Universal Stainless & Alloy
USAP
| $859K | ﹤0.01% |
19,504
+7,743
| +66% | +$335K |
|
Similar funds
Barclays's Q4 2024 Portfolio in Review
As of Q4 2024, Barclays held 5,604 positions worth $357B, down 5.3% from $377B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays withdrew a net $28.7B in Q4 2024, closing 348 positions and reducing 1,552 holdings. Its most notable exit was Stericycle Inc, an estimated $97.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Barclays opened a new position in iShares Bitcoin Trust worth $131M.
- Barclays's largest Q4 2024 buy was iShares Bitcoin Trust: 2,473,064 shares worth $131M.
- Barclays added most to Honeywell in Q4 2024, an estimated $3.92B increase.
- Barclays's biggest Q4 2024 reduction was Apple, cutting an estimated $4.41B.
- Barclays fully exited Stericycle Inc in Q4 2024, selling an estimated $97.3M.
- Barclays's ten largest holdings make up 41% of its $357B portfolio in Q4 2024.
- Barclays opened 343 new positions and closed 348 in Q4 2024.
- Barclays's portfolio value fell 5.3% quarter-over-quarter to $357B.
Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.